Background: Infant leukaemia is likely initiated in utero. Methods: We examined whether analgesic use during pregnancy was associated with risk by completing telephone interviews of the mothers of 441 infant leukaemia cases and 323 frequency-matched controls, using unconditional logistic regression. Results: With the exception of a reduced risk for infant acute myeloid leukaemias with non-aspirin non-steroidal anti-inflammatory drugs (NSAID) use early in pregnancy (odds ratios=0.60; confidence intervals: 0.37-0.97), no statistically significant associations were observed for aspirin, non-aspirin NSAIDs, or acetaminophen use in early pregnancy or after knowledge of pregnancy. Conclusion: Overall, analgesic use during pregnancy was not significantly associated with the risk of infant leukaemia.
Bibliographical noteFunding Information:
This work was supported by NIH R01 CA79940, U10 CA13539, U10 CA98543, U1098413, the Children’s Cancer Research Fund, Minneapolis, MN, and NIH P30 CA77588 (University of Minnesota Masonic Cancer Center shared resource: Health Survey Research Center).